ZEOX — Zeo ScientifiX, Inc.

OTC · Health Care · Biotechnology · CIK 1557376 ·
Last close
$1.70
Market Cap
$13.32M
52W High
$2.45
52W Low
$1.65
ADV30
5,022
Next earnings
Zeo ScientifiX, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. Its lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sources, which is in Phase I/II clinical trial to treat COVID-19, chronic obstructive pulmonary disease, osteoarthritis,and traumatic brain injury. The company also provides Patient Pure X, an autologous biologic, that helps reduce inflammation and promote tissue healing and regeneration. In addition, it develops and distributes products that incorporate its proprietary ingredients for products to be used in topical aesthetic applications; ZEO GROWX, ZEO HAIR GROW, and ZEO GROW BOOST, a serum comprised of hair growth stimulants for follicle stimulation. The company has a strategic collaboration with Regen Therapy Limited for the development of biologic therapeutics. The company was formerly known as Organicell Regenerative Medicine, Inc. and changed its name to Zeo ScientifiX, Inc. in February 2024. Zeo ScientifiX, Inc. was incorporated in 2011 and is based in Davie, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Apr 2026 2,581,000 2,055,000 -512,000 -145,000 3,886,000 1,846,000 3,174,000
Jan 2026 1,446,000 1,165,000 -878,000 -852,000 2,571,000 1,030,000 2,954,000
Oct 2025 1,654,000 1,398,000 -668,000 -815,000 1,527,000 221,000 2,950,000
Jul 2025 1,306,000 1,078,000 -2,071,000 -2,072,000 1,652,000 314,000 3,966,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,254,000
Investing CF
$-14,000
Financing CF
$1,601,000
CapEx
$-14,000
Dividends Paid
Buybacks
$-80,000
EPS Diluted TTM
$-0.86
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-68,586,000
Inventory
$502,000
Receivables
$63,000
ST Investments
EBIT TTM
$-5,044,000
Pretax Income TTM
$-5,130,000
Interest Exp TTM
$86,000
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$6,987,000
EBITDA
$-4,052,000
Free Cash Flow
$1,065,500
Enterprise Value
$11,977,399
Total Cash
$1,846,000
Total Debt
$343,000
Shares Out
7,837,441
Trailing EPS
$-0.78
Book Value
$-0.05
ROE
ROA
-97.0%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Oct 2025 5,199,000 -5,386,000 -5,521,000 1,527,000 2,950,000 -718,000
Oct 2024 4,620,000 -5,319,000 -4,705,000 1,643,000 3,296,000 -1,450,000
Oct 2023 4,558,000 -6,768,000 -6,987,000 2,782,000 4,023,000 -2,197,000
Oct 2022 6,491,008 -8,842,960 -8,896,557 6,200,688 4,312,084 -3,165,840
Oct 2021

Peers — same industry

TickerNameMarket CapLastDaily %
JSPR Jasper Therapeutics, Inc. $13.20M $0.47
CKDXF Opthea Ltd $13.68M $0.01
INAB IN8BIO, INC. $14.10M $1.47
BCDA BioCardia, Inc. $14.10M $0.95
ZIVO Zivo Bioscience, Inc. $15.32M $3.69

News headlines (Yahoo Finance, 1h cache)

ZEO ScientifiX Donates Products to Support Pediatric Burn Reconstruction Mission in Peru
2026-06-16 11:00 · Yahoo
ZEO ScientifiX Expands Medical Advisory Board with Leaders in Regenerative and Longevity Medicine
2026-06-09 11:00 · Yahoo
ZEO ScientifiX Launches Physician-Led Patient Masterclass Program Following Grassroots Demand in the Southeast
2026-05-27 11:00 · Yahoo
ZEO ScientifiX Announces That Unaudited Monthly Sales Surpassed $1.0 million in April 2026, the First Time The Company Has Achieved This Milestone.
2026-05-12 11:00 · Yahoo
ZEO ScientifiX Surpasses 500 Physicians Trained in Regenerative Medicine Compliance; Monthly Masterclasses Average 70+ Clinicians
2026-04-21 11:00 · Yahoo
Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics--Powered by an Exclusive Scientific and Biologics Strategic Collaboration
2026-04-09 11:00 · Yahoo
Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics - Powered by an Exclusive Scientific and Biologics Strategic Collaboration
2026-04-09 11:00 · Yahoo
ZEO ScientifiX (OTCQB: ZEOX) Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage
2026-04-07 17:56 · Yahoo
Cytora Therapeutics, Made Scientific, and Zeo ScientifiX Announce Partnership to Manufacture and Commercialize Cytora's Allogeneic Stem Cell Therapy in the United States
2026-01-07 12:45 · Yahoo
ZEO ScientifiX(TM) Positioned for New Growth as Florida Opens Stem Cell Market
2025-10-23 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.